Fmr LLC Trims Position in Corindus Vascular Robotics Inc (CVRS)

FMR LLC lessened its position in shares of Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) by 20.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,000,000 shares of the medical equipment provider’s stock after selling 1,315,800 shares during the quarter. FMR LLC owned about 2.61% of Corindus Vascular Robotics worth $4,200,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVRS. Millennium Management LLC boosted its holdings in shares of Corindus Vascular Robotics by 1.0% in the 4th quarter. Millennium Management LLC now owns 7,088,692 shares of the medical equipment provider’s stock worth $5,955,000 after purchasing an additional 68,250 shares during the period. Nomura Holdings Inc. raised its position in shares of Corindus Vascular Robotics by 18.6% in the 4th quarter. Nomura Holdings Inc. now owns 1,262,445 shares of the medical equipment provider’s stock worth $1,077,000 after acquiring an additional 198,111 shares in the last quarter. Barclays PLC bought a new position in shares of Corindus Vascular Robotics in the 4th quarter worth $325,000. Citadel Advisors LLC raised its position in shares of Corindus Vascular Robotics by 205.4% in the 3rd quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock worth $164,000 after acquiring an additional 77,829 shares in the last quarter. Finally, Virtu Financial LLC bought a new position in shares of Corindus Vascular Robotics in the 4th quarter worth $64,000.

In other Corindus Vascular Robotics news, Director Louis A. Cannon acquired 573,798 shares of the stock in a transaction that occurred on Tuesday, March 12th. The stock was bought at an average cost of $1.38 per share, for a total transaction of $791,841.24. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Hudson Executive Capital Lp acquired 2,899,391 shares of the stock in a transaction that occurred on Tuesday, March 12th. The stock was acquired at an average price of $1.38 per share, with a total value of $4,001,159.58. The disclosure for this purchase can be found here. Insiders have acquired 3,483,189 shares of company stock valued at $4,811,001 in the last three months.

Shares of NYSEAMERICAN:CVRS opened at $2.17 on Monday. Corindus Vascular Robotics Inc has a 1 year low of $0.70 and a 1 year high of $2.54.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last issued its earnings results on Tuesday, March 12th. The medical equipment provider reported ($0.04) EPS for the quarter, hitting analysts’ consensus estimates of ($0.04). The company had revenue of $4.67 million during the quarter, compared to analysts’ expectations of $5.60 million.

COPYRIGHT VIOLATION WARNING: This story was originally posted by Finance Daily and is owned by of Finance Daily. If you are viewing this story on another domain, it was stolen and republished in violation of US and international trademark and copyright law. The original version of this story can be accessed at https://www.fidaily.com/2019/05/06/fmr-llc-sells-1315800-shares-of-corindus-vascular-robotics-inc-cvrs.html.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures.

Featured Article: How to calculate compound interest

Receive News & Ratings for Corindus Vascular Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Corindus Vascular Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.